{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:59:41Z","timestamp":1780142381709,"version":"3.54.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Evaluating High-Resolution Optical Coherence Tomography (HR-OCT) versus standard spectral domain OCT in pigmented choroidal lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We screened a total of 40 subjects with pigmented choroidal lesions. Lesions were imaged on HR-OCT and standard OCT devices with and without enhanced depth imaging (EDI) mode. Images were graded for qualitative and quantitative aspects, like choriocapillaris compression and width, choroidal reflectivity and thickness, amongst others.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>32 of the 40 subjects could be included in the image analysis, the rest were excluded due to insufficient imaging. HR-OCT EDI mode allowed visualization of the posterior choroidal extent in 11 lesions (11\/32\u2009=\u200934.4%) versus in six (6\/32; 18.8%), four (4\/30; 13.3%), and five cases (5\/30; 16.7%) in normal HR-OCT (<jats:italic>n<\/jats:italic>\u2009=\u200932), standard OCT (<jats:italic>n<\/jats:italic>\u2009=\u200930) and OCT EDI mode (<jats:italic>n<\/jats:italic>\u2009=\u200930), respectively, albeit not significantly different. Choriocapillaris compression was evident in 10 cases on HR-OCT and equally visible in all imaging modes. Mean choriocapillaris thickness ranged from 11.6 to 13.9 microns (SD range 3.84\u20134.33), and compressed choriocapillaris thickness similarly ranged from a mean of 7.1 to 7.8 microns (SD range 2.20\u20133.55). Image quality declined significantly towards the periphery in three out of four modes (<jats:italic>p<\/jats:italic>\u2009=\u20090.0077 to <jats:italic>p<\/jats:italic>\u2009=\u20090.29).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>HR-OCT may provide better visibility of retinal and choroidal structures in pigmented choroidal lesions, although image quality is reduced in attempting to image peripheral lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Translational relevance<\/jats:title>\n            <jats:p>The prototype HR-OCT offers insights into clinical features of pigmented choroidal lesions that are not apparent on conventional OCT imaging. This supports the development of HR-OCTolution OCT devices.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00645-w","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:37:45Z","timestamp":1740746265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High-resolution optical coherence tomography in pigmented choroidal lesions"],"prefix":"10.1186","volume":"11","author":[{"given":"Damian","family":"Jaggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalin G.","family":"Aeberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Artemiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Zinkernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M.","family":"Heussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"7","key":"645_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.12.7.12","volume":"12","author":"J Reche","year":"2023","unstructured":"Reche J, Stocker AB, Henchoz V, et al. High-Resolution optical coherence tomography in healthy individuals provides resolution at the cellular and subcellular levels. Trans Vis Sci Tech. 2023;12(7):12. https:\/\/doi.org\/10.1167\/tvst.12.7.12.","journal-title":"Trans Vis Sci Tech"},{"issue":"12","key":"645_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/tvst.13.12.19","volume":"13","author":"L Goerdt","year":"2024","unstructured":"Goerdt L, Swain TA, Kar D, et al. Band visibility in High-Resolution optical coherence tomography assessed with a custom review tool and updated, Histology-Derived nomenclature. Transl Vis Sci Technol. 2024;13(12):19. https:\/\/doi.org\/10.1167\/tvst.13.12.19.","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"645_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.oret.2023.10.011","volume":"8","author":"A Mahmoudi","year":"2024","unstructured":"Mahmoudi A, Corradetti G, Emamverdi M, et al. Atrophic lesions associated with Age-Related macular degeneration: High-Resolution versus standard OCT. Ophthalmol Retina. 2024;8(4):367\u201375. https:\/\/doi.org\/10.1016\/j.oret.2023.10.011.","journal-title":"Ophthalmol Retina"},{"key":"645_CR4","doi-asserted-by":"publisher","unstructured":"Herskowitz WR, De Arrigunaga S, Greenfield JA, Cohen NK, Galor A, Karp CL. Can high-resolution optical coherence tomography provide an optical biopsy for ocular surface lesions? Can J Ophthalmol. Published online August 3, 2024:S0008-4182(24)00214-X. https:\/\/doi.org\/10.1016\/j.jcjo.2024.07.001","DOI":"10.1016\/j.jcjo.2024.07.001"},{"issue":"1","key":"645_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12886-019-1237-4","volume":"19","author":"YS Shen","year":"2019","unstructured":"Shen YS, Hu JL, Hu CC. Anterior high-resolution OCT in the diagnosis and management of corneal squamous hyperplasia mimicking a malignancy: a case report. BMC Ophthalmol. 2019;19(1):235. https:\/\/doi.org\/10.1186\/s12886-019-1237-4.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"645_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.14.1.12","volume":"14","author":"K Wall","year":"2025","unstructured":"Wall K, Arend LP, von der Emde L, Sa\u00dfmannshausen M, Holz FG, Ach T. Characterization of the disorganization of the inner retinal layers in diabetics using increased axial resolution optical coherence tomography. Transl Vis Sci Technol. 2025;14(1):12. https:\/\/doi.org\/10.1167\/tvst.14.1.12.","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"645_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ophtha.2011.11.001","volume":"119","author":"SU Shah","year":"2012","unstructured":"Shah SU, Kaliki S, Shields CL, Ferenczy SR, Harmon SA, Shields JA. Enhanced depth imaging optical coherence tomography of choroidal nevus in 104 cases. Ophthalmology. 2012;119(5):1066\u201372. https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.001.","journal-title":"Ophthalmology"},{"issue":"6","key":"645_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.oret.2017.10.006","volume":"2","author":"JJ Toledo","year":"2018","unstructured":"Toledo JJ, Asencio M, Garc\u00eda JR, Morales LA, Tomkinson C, Cajigal C. OCT angiography: imaging of choroidal and retinal tumors. Ophthalmol Retina. 2018;2(6):613\u201322. https:\/\/doi.org\/10.1016\/j.oret.2017.10.006.","journal-title":"Ophthalmol Retina"},{"issue":"13","key":"645_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.64.13.1","volume":"64","author":"Z Mahoun","year":"2023","unstructured":"Mahoun Z, Malaise D, Lumbroso-Le Rouic L, Levy-Gabriel C, Cassoux N, Matet A. Optical density ratio of subretinal fluid in choroidal melanomas versus choroidal Naevi assessed by optical coherence tomography. Invest Ophthalmol Vis Sci. 2023;64(13):1. https:\/\/doi.org\/10.1167\/iovs.64.13.1.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"645_CR10","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1097\/IAE.0000000000002440","volume":"39","author":"CL Shields","year":"2019","unstructured":"Shields CL, Dalvin LA, Ancona-Lezama D, et al. Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and victor T. Curtin lecture. Retina. 2019;39(10):1840\u201351. https:\/\/doi.org\/10.1097\/IAE.0000000000002440.","journal-title":"Retina"},{"issue":"5","key":"645_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147(5):811\u20135. https:\/\/doi.org\/10.1016\/j.ajo.2008.12.008.","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"645_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.ophtha.2020.03.025","volume":"127","author":"MD Yu","year":"2020","unstructured":"Yu MD, Dalvin LA, Ancona-Lezama D, et al. Choriocapillaris compression correlates with choroidal Nevus\u2013Associated subretinal fluid: OCT analysis of 3431 cases. Ophthalmology. 2020;127(9):1273\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2020.03.025.","journal-title":"Ophthalmology"},{"issue":"2","key":"645_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4049\/jimmunol.165.2.710","volume":"165","author":"AC Repp","year":"2000","unstructured":"Repp AC, Mayhew ES, Apte S, Niederkorn JY. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent Lysis by NK cells. J Immunol. 2000;165(2):710\u20135. https:\/\/doi.org\/10.4049\/jimmunol.165.2.710.","journal-title":"J Immunol"},{"issue":"9","key":"645_CR14","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.3390\/ijms25094849","volume":"25","author":"CN Valdez","year":"2024","unstructured":"Valdez CN, S\u00e1nchez-Zuno GA, Bucala R, Tran TT. Macrophage migration inhibitory factor (MIF) and D-Dopachrome tautomerase (DDT): pathways to tumorigenesis and therapeutic opportunities. Int J Mol Sci. 2024;25(9):4849. https:\/\/doi.org\/10.3390\/ijms25094849.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"645_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/IAE.0b013e318296f681","volume":"33","author":"S Mrejen","year":"2013","unstructured":"Mrejen S, Fung AT, Silverman RH, Kendall C, Freund KB. Potential pitfalls in measuring the thickness of small choroidal melanocytic tumors with ultrasonography. Retina. 2013;33(7):1293\u20139. https:\/\/doi.org\/10.1097\/IAE.0b013e318296f681.","journal-title":"Retina"},{"issue":"11","key":"645_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamaophthalmol.2016.3633","volume":"134","author":"MW Rodrigues","year":"2016","unstructured":"Rodrigues MW, Correa ZM, Say EA, et al. Photoreceptor arrangement changes secondary to choroidal nevus. JAMA Ophthalmol. 2016;134(11):1315. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.3633.","journal-title":"JAMA Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00645-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:37:47Z","timestamp":1740746267000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00645-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00645-w","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave written informed consent to participate in the study. The study was conducted in accordance with the Swiss Human Research Act, the ICH guidelines of Good Clinical Practice, the Declaration of Helsinki and was authorized by the local ethics committee (Kantonale Ethikkomission Bern, KEK, BASEC-ID. 2021-D0038).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"D. Jaggi, Bayer (R); S.G. Aeberhard, None; D. Artemiev, None; M.S. Zinkernagel, Bayer (F, C), Novartis (C), Roche (C); F.M. Heussen, Bayer (F, R), Carl Zeiss Meditec (C), Oertli (C), Roche (C).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}